Inverna
Invenra is a leader in antibody discovery and multispecific platform technologies, providing innovative solutions to accelerate and streamline the development of next-generation therapeutics across diverse formats. Our established B-Body® platform enables rapid, high-throughput discovery and generation of robustly manufacturable bispecific antibodies. Building on this success, our new T-Body™ platform is purpose-built for trispecific antibodies, designed to overcome key developability hurdles often faced with complex formats like advanced T-cell engagers through superior expression, efficient assembly, and simplified purification. By integrating proprietary antibody libraries and high-throughput screening methodologies with these versatile ‘Plug & Play’ platforms, Invenra empowers partners to efficiently translate complex biology into effective therapeutic candidates targeting cancer and immune diseases faster and more effectively.
